Maternal substance use and integrated treatment programs for women with substance abuse issues and their children: a meta-analysis.
BACKGROUND
The rate of women with substance abuse issues is increasing. Women present with a unique constellation of risk factors and presenting needs, which may include specific needs in their role as mothers. Numerous integrated programs (those with substance use treatment and pregnancy, parenting, or child services) have been developed to specifically meet the needs of pregnant and parenting women with substance abuse issues. This synthesis and meta-analysis reviews research in this important and growing area of treatment.


METHODS
We searched PsycINFO, MedLine, PubMed, Web of Science, EMBASE, Proquest Dissertations, Sociological Abstracts, and CINAHL and compiled a database of 21 studies (2 randomized trials, 9 quasi-experimental studies, 10 cohort studies) of integrated programs published between 1990 and 2007 with outcome data on maternal substance use. Data were summarized and where possible, meta-analyses were performed, using standardized mean differences (d) effect size estimates.


RESULTS
In the two studies comparing integrated programs to no treatment, effect sizes for urine toxicology and percent using substances significantly favored integrated programs and ranged from 0.18 to 1.41. Studies examining changes in maternal substance use from beginning to end of treatment were statistically significant and medium sized. More specifically, in the five studies measuring severity of drug and alcohol use, the average effect sizes were 0.64 and 0.40, respectively. In the four cohort studies of days of use, the average effect size was 0.52. Of studies comparing integrated to non-integrated programs, four studies assessed urine toxicology and two assessed self-reported abstinence. Overall effect sizes for each measure were not statistically significant (d = -0.09 and 0.22, respectively).


CONCLUSIONS
Findings suggest that integrated programs are effective in reducing maternal substance use. However, integrated programs were not significantly more effective than non-integrated programs. Policy implications are discussed with specific attention to the need for funding of high quality randomized control trials and improved reporting practices.
Milligan
Karen
K
Integra, 25 Imperial Street, Toronto, ON, M5P 1B9, Canada. kmilligan@integra.on.ca
Niccols
Alison
A
Sword
Wendy
W
Thabane
Lehana
L
Henderson
Joanna
J
Smith
Ainsley
A
Liu
Jennifer
J
D005260:Female; D006801:Humans; D009034:Mother-Child Relations; D019966:Substance-Related Disorders / Q000628:therapy*
Health Soc Care Community. 2003 Mar;11(2):85-94
14629210
Harv Rev Psychiatry. 2002 Mar-Apr;10(2):76-85
11897748
J Subst Abuse Treat. 1992 Fall;9(4):327-30
1479630
Addiction. 2000 Nov;95 Suppl 3:S419-38
11132366
Drug Alcohol Depend. 2004 Jun 11;74(3):265-72
15194204
Int J Addict. 1995 Feb;30(3):259-73
7790127
Am J Drug Alcohol Abuse. 2000 May;26(2):207-27
10852357
J Gen Intern Med. 2002 May;17(5):387-97
12047738
Adm Policy Ment Health. 2004 Mar;31(4):313-38
15285208
Subst Use Misuse. 1996 Mar;31(4):423-35
8851810
Phys Ther. 2008 Feb;88(2):156-75
18073267
J Stud Alcohol. 1997 Jan;58(1):7-29
8979210
Addict Behav. 2004 Jun;29(4):731-41
15135555
Control Clin Trials. 1986 Sep;7(3):177-88
3802833
J Subst Abuse Treat. 1999 Apr;16(3):265-75
10194744
Am J Drug Alcohol Abuse. 2003;29(1):19-53
12731680
J Subst Abuse Treat. 1999 Jul-Sep;17(1-2):139-48
10435262
Addiction. 1998 Jan;93(1):73-92
9624713
J Stud Alcohol. 1998 Mar;59(2):152-62
9500302
Eval Rev. 2003 Dec;27(6):656-80
14650279
J Subst Abuse Treat. 2001 Sep;21(2):67-75
11551735
Drug Alcohol Depend. 2002 Jun 1;67(1):53-72
12062779
J Subst Abuse Treat. 2004 Oct;27(3):179-85
15501370
Drug Alcohol Rev. 2004 Dec;23(4):471-81
15763752
J Subst Abuse Treat. 1998 Mar-Apr;15(2):143-50
9561954
Addict Behav. 1995 Jul-Aug;20(4):533-42
7484335
J Perinatol. 2003 Jan;23(1):3-9
12556919
J Subst Abuse Treat. 1998 May-Jun;15(3):175-6
9633028
Health Soc Work. 1994 Feb;19(1):7-15
8168782
J Subst Abuse Treat. 2000 Jan;18(1):41-9
10636605
Int J Technol Assess Health Care. 1996 Spring;12(2):195-208
8707495
J Am Geriatr Soc. 2003 Oct;51(10):1484-9
14511173
J Clin Epidemiol. 2009 Feb;62(2):149-57
18722088
J Midwifery Womens Health. 2002 Sep-Oct;47(5):371-9
12361349
Subst Abuse Treat Prev Policy. 2009 Feb 18;4:2
19226454
J Clin Epidemiol. 2004 Apr;57(4):349-57
15135835
Ann N Y Acad Sci. 1989;562:8-13
2742287
Dev Psychopathol. 2007 Winter;19(1):243-61
17241493
J Public Health Manag Pract. 1999 Sep;5(5):86-97
10558389